{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:19:39Z","timestamp":1790777979098,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Envir Health Rpt"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s40572-019-00231-x","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T02:35:41Z","timestamp":1557801341000},"page":"95-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Understanding Environmental Contaminants\u2019 Direct Effects on Non-alcoholic Fatty Liver Disease Progression"],"prefix":"10.1007","volume":"6","author":[{"given":"Laura E.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"4","key":"231_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0192623314549960","volume":"43","author":"L Al-Eryani","year":"2015","unstructured":"\u2022 Al-Eryani L, Wahlang B, Falkner KC, Guardiola JJ, Clair HB, Prough RA, et al. Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents. Toxicol Pathol. 2015;43(4):482\u201397. \n                      https:\/\/doi.org\/10.1177\/0192623314549960\n                      \n                    \n                              This review of the current literature provides evidence for the impact that environmental chemicals have on the development of steatosis. An emphasis is placed on the novel findings of fungicides and herbicides contributing to TAFLD, compared to insecticides.","journal-title":"Toxicol Pathol"},{"issue":"4","key":"231_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jcmgh.2015.05.006","volume":"1","author":"S Joshi-Barve","year":"2015","unstructured":"Joshi-Barve S, Kirpich I, Cave MC, Marsano LS, McClain CJ. Alcoholic, nonalcoholic, and toxicant-associated steatohepatitis: mechanistic similarities and differences. Cell Mol Gastroenterol Hepatol. 2015;1(4):356\u201367. \n                      https:\/\/doi.org\/10.1016\/j.jcmgh.2015.05.006\n                      \n                    .","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"231_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"\u2022 Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123\u201333. \n                      https:\/\/doi.org\/10.1002\/hep.29466\n                      \n                    \n                              This publication emphasizes the growing prevalence and the increasing burden of NAFLD, and therefore provides essential significance in the need for greater understanding of risk factors and mechanisms that contribute to the disease.","journal-title":"Hepatology."},{"issue":"3","key":"231_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547\u201355. \n                      https:\/\/doi.org\/10.1053\/j.gastro.2014.11.039\n                      \n                    .","journal-title":"Gastroenterology."},{"issue":"11","key":"231_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin M, Vipani A, Bresee C, Todo T, Kim IK, Alkhouri N, et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol. 2018;113(11):1649\u201359. \n                      https:\/\/doi.org\/10.1038\/s41395-018-0088-6\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"issue":"14","key":"231_CR6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3748\/wjg.v24.i14.1491","volume":"24","author":"I Mikolasevic","year":"2018","unstructured":"Mikolasevic I, Filipec-Kanizaj T, Mijic M, Jakopcic I, Milic S, Hrstic I, et al. Nonalcoholic fatty liver disease and liver transplantation - where do we stand? World J Gastroenterol. 2018;24(14):1491\u2013506. \n                      https:\/\/doi.org\/10.3748\/wjg.v24.i14.1491\n                      \n                    .","journal-title":"World J Gastroenterol"},{"issue":"5","key":"231_CR7","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836\u201346. \n                      https:\/\/doi.org\/10.1002\/hep.24001\n                      \n                    .","journal-title":"Hepatology."},{"issue":"8","key":"231_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348. \n                      https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012\n                      \n                    .","journal-title":"Metabolism."},{"issue":"2","key":"231_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/hep.23321","volume":"51","author":"M Cave","year":"2010","unstructured":"Cave M, Falkner KC, Ray M, Joshi-Barve S, Brock G, Khan R, et al. Toxicant-associated steatohepatitis in vinyl chloride workers. Hepatology. 2010;51(2):474\u201381. \n                      https:\/\/doi.org\/10.1002\/hep.23321\n                      \n                    .","journal-title":"Hepatology."},{"issue":"1","key":"231_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357. \n                      https:\/\/doi.org\/10.1002\/hep.29367\n                      \n                    .","journal-title":"Hepatology."},{"issue":"2","key":"231_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2605.2008.00870.x","volume":"31","author":"AA Jensen","year":"2008","unstructured":"Jensen AA, Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl. 2008;31(2):161\u20139. \n                      https:\/\/doi.org\/10.1111\/j.1365-2605.2008.00870.x\n                      \n                    .","journal-title":"Int J Androl"},{"issue":"12","key":"231_CR12","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1289\/ehp.0800379","volume":"117","author":"SJ Frisbee","year":"2009","unstructured":"Frisbee SJ, Brooks AP Jr, Maher A, Flensborg P, Arnold S, Fletcher T, et al. The C8 health project: design, methods, and participants. Environ Health Perspect. 2009;117(12):1873\u201382. \n                      https:\/\/doi.org\/10.1289\/ehp.0800379\n                      \n                    .","journal-title":"Environ Health Perspect"},{"key":"231_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.envpol.2019.01.064","volume":"247","author":"J Bassler","year":"2019","unstructured":"Bassler J, Ducatman A, Elliott M, Wen S, Wahlang B, Barnett J, et al. Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. Environ Pollut. 2019;247:1055\u201363. \n                      https:\/\/doi.org\/10.1016\/j.envpol.2019.01.064\n                      \n                    .","journal-title":"Environ Pollut"},{"issue":"6","key":"231_CR14","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/ajg.2009.707","volume":"105","author":"CY Lin","year":"2010","unstructured":"Lin CY, Lin LY, Chiang CK, Wang WJ, Su YN, Hung KY, et al. Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am J Gastroenterol. 2010;105(6):1354\u201363. \n                      https:\/\/doi.org\/10.1038\/ajg.2009.707\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"key":"231_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.envres.2014.10.004","volume":"136","author":"JA Gleason","year":"2015","unstructured":"Gleason JA, Post GB, Fagliano JA. Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007-2010. Environ Res. 2015;136:8\u201314. \n                      https:\/\/doi.org\/10.1016\/j.envres.2014.10.004\n                      \n                    .","journal-title":"Environ Res"},{"key":"231_CR16","doi-asserted-by":"crossref","unstructured":"\u2022 Jain RB. Selective associations of recent low concentrations of perfluoroalkyl substances with liver function biomarkers: NHANES 2011\u20132014 data on US adults aged>20 years. J Occup Environ Med. 2019;61(4):293\u2013302. This publication provides essential analysis of more recent population stastics regarding PFAS concentrations, and significant findings in obese participants compared to non-obese participants emphasizing the potential role PFAS have in NAFLD.","DOI":"10.1097\/JOM.0000000000001532"},{"key":"231_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tox.2016.12.007","volume":"378","author":"KP Das","year":"2017","unstructured":"Das KP, Wood CR, Lin MT, Starkov AA, Lau C, Wallace KB, et al. Perfluoroalkyl acids-induced liver steatosis: effects on genes controlling lipid homeostasis. Toxicology. 2017;378:37\u201352. \n                      https:\/\/doi.org\/10.1016\/j.tox.2016.12.007\n                      \n                    .","journal-title":"Toxicology."},{"issue":"9","key":"231_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00204-014-1322-7","volume":"89","author":"S Yan","year":"2015","unstructured":"Yan S, Wang J, Dai J. Activation of sterol regulatory element-binding proteins in mice exposed to perfluorooctanoic acid for 28 days. Arch Toxicol. 2015;89(9):1569\u201378. \n                      https:\/\/doi.org\/10.1007\/s00204-014-1322-7\n                      \n                    .","journal-title":"Arch Toxicol"},{"issue":"31","key":"231_CR19","doi-asserted-by":"publisher","first-page":"24201","DOI":"10.1007\/s11356-017-0072-5","volume":"24","author":"X Wu","year":"2017","unstructured":"Wu X, Liang M, Yang Z, Su M, Yang B. Effect of acute exposure to PFOA on mouse liver cells in vivo and in vitro. Environ Sci Pollut Res Int. 2017;24(31):24201\u20136. \n                      https:\/\/doi.org\/10.1007\/s11356-017-0072-5\n                      \n                    .","journal-title":"Environ Sci Pollut Res Int"},{"key":"231_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2019.01.017","volume":"416","author":"X Li","year":"2019","unstructured":"Li X, Wang Z, Klaunig JE. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. Toxicology. 2019;416:1\u201314. \n                      https:\/\/doi.org\/10.1016\/j.tox.2019.01.017\n                      \n                    .","journal-title":"Toxicology."},{"issue":"2","key":"231_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/en.2015-1866","volume":"157","author":"CG Wilson","year":"2016","unstructured":"Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology. 2016;157(2):570\u201385. \n                      https:\/\/doi.org\/10.1210\/en.2015-1866\n                      \n                    .","journal-title":"Endocrinology."},{"issue":"6","key":"231_CR22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","volume":"68","author":"P Zhang","year":"2018","unstructured":"Zhang P, Ge Z, Wang H, Feng W, Sun X, Chu X, et al. Prolactin improves hepatic steatosis via CD36 pathway. J Hepatol. 2018;68(6):1247\u201355. \n                      https:\/\/doi.org\/10.1016\/j.jhep.2018.01.035\n                      \n                    .","journal-title":"J Hepatol"},{"key":"231_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.taap.2016.05.001","volume":"304","author":"KM Beggs","year":"2016","unstructured":"Beggs KM, McGreal SR, McCarthy A, Gunewardena S, Lampe JN, Lau C, et al. The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction. Toxicol Appl Pharmacol. 2016;304:18\u201329. \n                      https:\/\/doi.org\/10.1016\/j.taap.2016.05.001\n                      \n                    .","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"231_CR24","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1002\/jcp.26270","volume":"233","author":"D Yu","year":"2018","unstructured":"Yu D, Chen G, Pan M, Zhang J, He W, Liu Y, et al. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4alpha and leads to hepatic steatosis in mice. J Cell Physiol. 2018;233(6):4770\u201382. \n                      https:\/\/doi.org\/10.1002\/jcp.26270\n                      \n                    .","journal-title":"J Cell Physiol"},{"issue":"6","key":"231_CR25","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s00204-016-1888-3","volume":"91","author":"T Abe","year":"2017","unstructured":"Abe T, Takahashi M, Kano M, Amaike Y, Ishii C, Maeda K, et al. Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid. Arch Toxicol. 2017;91(6):2365\u201374. \n                      https:\/\/doi.org\/10.1007\/s00204-016-1888-3\n                      \n                    .","journal-title":"Arch Toxicol"},{"issue":"5","key":"231_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/1091581818790934","volume":"37","author":"I Huck","year":"2018","unstructured":"Huck I, Beggs K, Apte U. Paradoxical protective effect of Perfluorooctanesulfonic acid against high-fat diet-induced hepatic steatosis in mice. Int J Toxicol. 2018;37(5):383\u201392. \n                      https:\/\/doi.org\/10.1177\/1091581818790934\n                      \n                    .","journal-title":"Int J Toxicol"},{"issue":"12","key":"231_CR27","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1289\/ehp.1002720","volume":"118","author":"M Cave","year":"2010","unstructured":"Cave M, Appana S, Patel M, Falkner KC, McClain CJ, Brock G. Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004. Environ Health Perspect. 2010;118(12):1735\u201342. \n                      https:\/\/doi.org\/10.1289\/ehp.1002720\n                      \n                    .","journal-title":"Environ Health Perspect"},{"issue":"2","key":"231_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/toxsci\/kfu083","volume":"140","author":"B Wahlang","year":"2014","unstructured":"Wahlang B, Falkner KC, Clair HB, Al-Eryani L, Prough RA, States JC, et al. Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. Toxicol Sci. 2014a;140(2):283\u201397. \n                      https:\/\/doi.org\/10.1093\/toxsci\/kfu083\n                      \n                    .","journal-title":"Toxicol Sci"},{"issue":"3","key":"231_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.taap.2014.06.019","volume":"279","author":"B Wahlang","year":"2014","unstructured":"Wahlang B, Song M, Beier JI, Cameron Falkner K, Al-Eryani L, Clair HB, et al. Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease. Toxicol Appl Pharmacol. 2014b;279(3):380\u201390. \n                      https:\/\/doi.org\/10.1016\/j.taap.2014.06.019\n                      \n                    .","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"231_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/toxsci\/kfv250","volume":"149","author":"B Wahlang","year":"2016","unstructured":"Wahlang B, Prough RA, Falkner KC, Hardesty JE, Song M, Clair HB, et al. Polychlorinated biphenyl-xenobiotic nuclear receptor interactions regulate energy metabolism, behavior, and inflammation in non-alcoholic-steatohepatitis. Toxicol Sci. 2016;149(2):396\u2013410. \n                      https:\/\/doi.org\/10.1093\/toxsci\/kfv250\n                      \n                    .","journal-title":"Toxicol Sci"},{"issue":"3","key":"231_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.taap.2014.06.016","volume":"279","author":"MC Ferrante","year":"2014","unstructured":"Ferrante MC, Amero P, Santoro A, Monnolo A, Simeoli R, Di Guida F, et al. Polychlorinated biphenyls (PCB 101, PCB 153 and PCB 180) alter leptin signaling and lipid metabolism in differentiated 3T3-L1 adipocytes. Toxicol Appl Pharmacol. 2014;279(3):401\u20138. \n                      https:\/\/doi.org\/10.1016\/j.taap.2014.06.016\n                      \n                    .","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"231_CR32","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.jnutbio.2013.01.009","volume":"24","author":"B Wahlang","year":"2013","unstructured":"Wahlang B, Falkner KC, Gregory B, Ansert D, Young D, Conklin DJ, et al. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6\/J mice. J Nutr Biochem. 2013;24(9):1587\u201395. \n                      https:\/\/doi.org\/10.1016\/j.jnutbio.2013.01.009\n                      \n                    .","journal-title":"J Nutr Biochem"},{"issue":"2","key":"231_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.taap.2011.08.002","volume":"256","author":"AK Kopec","year":"2011","unstructured":"Kopec AK, D'Souza ML, Mets BD, Burgoon LD, Reese SE, Archer KJ, et al. Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2\u2032,4,4\u2032,5,5\u2032-hexachlorobiphenyl (PCB153) co-treatment in C57BL\/6 mice. Toxicol Appl Pharmacol. 2011;256(2):154\u201367. \n                      https:\/\/doi.org\/10.1016\/j.taap.2011.08.002\n                      \n                    .","journal-title":"Toxicol Appl Pharmacol"},{"key":"231_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-015-0218-2","volume":"14","author":"MP Boucher","year":"2015","unstructured":"Boucher MP, Lefebvre C, Chapados NA. The effects of PCB126 on intra-hepatic mechanisms associated with non alcoholic fatty liver disease. J Diabetes Metab Disord. 2015;14:88. \n                      https:\/\/doi.org\/10.1186\/s40200-015-0218-2\n                      \n                    .","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"231_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/toxsci\/kfv215","volume":"149","author":"GS Gadupudi","year":"2016","unstructured":"Gadupudi GS, Klaren WD, Olivier AK, Klingelhutz AJ, Robertson LW. PCB126-induced disruption in gluconeogenesis and fatty acid oxidation precedes fatty liver in male rats. Toxicol Sci. 2016;149(1):98\u2013110. \n                      https:\/\/doi.org\/10.1093\/toxsci\/kfv215\n                      \n                    .","journal-title":"Toxicol Sci"},{"issue":"8","key":"231_CR36","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00204-018-2235-7","volume":"92","author":"R Mesnage","year":"2018","unstructured":"Mesnage R, Biserni M, Balu S, Frainay C, Poupin N, Jourdan F, et al. Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in HepaRG liver cells exposed to PCB 126. Arch Toxicol. 2018;92(8):2533\u201347. \n                      https:\/\/doi.org\/10.1007\/s00204-018-2235-7\n                      \n                    .","journal-title":"Arch Toxicol"},{"issue":"1","key":"231_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4331\/wjbc.v9.i1.1","volume":"9","author":"J Fujii","year":"2018","unstructured":"Fujii J, Homma T, Kobayashi S, Seo HG. Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease. World J Biol Chem. 2018;9(1):1\u201315. \n                      https:\/\/doi.org\/10.4331\/wjbc.v9.i1.1\n                      \n                    .","journal-title":"World J Biol Chem"},{"key":"231_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.chemosphere.2018.10.196","volume":"217","author":"P Deng","year":"2019","unstructured":"\u2022 Deng P, Barney J, Petriello MC, Morris AJ, Wahlang B, Hennig B. Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunction. Chemosphere. 2019;217:140\u20139. \n                      https:\/\/doi.org\/10.1016\/j.chemosphere.2018.10.196\n                      \n                    \n                              This study demonstrates the power of metabolomics to assess toxicant-induced metabolic disurbances. Specifically, it was shown that PCB 126 alters the metabolome, metabolic processes, and contributes to altered redox status providing novel effects of PCB 126 during impaired liver status, and the importance of these disturbances to disease risk.","journal-title":"Chemosphere."},{"issue":"2","key":"231_CR39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/toxsci\/kfx275","volume":"162","author":"MC Petriello","year":"2018","unstructured":"Petriello MC, Brandon JA, Hoffman J, Wang C, Tripathi H, Abdel-Latif A, et al. Dioxin-like PCB 126 increases systemic inflammation and accelerates atherosclerosis in lean LDL receptor-deficient mice. Toxicol Sci. 2018;162(2):548\u201358. \n                      https:\/\/doi.org\/10.1093\/toxsci\/kfx275\n                      \n                    .","journal-title":"Toxicol Sci"},{"issue":"2","key":"231_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/toxsci\/kfx180","volume":"160","author":"B Wahlang","year":"2017","unstructured":"Wahlang B, Barney J, Thompson B, Wang C, Hamad OM, Hoffman JB, et al. Editor's highlight: PCB126 exposure increases risk for peripheral vascular diseases in a liver injury mouse model. Toxicol Sci. 2017;160(2):256\u201367. \n                      https:\/\/doi.org\/10.1093\/toxsci\/kfx180\n                      \n                    .","journal-title":"Toxicol Sci"},{"issue":"39","key":"231_CR41","doi-asserted-by":"publisher","first-page":"10132","DOI":"10.1021\/acs.jafc.8b03177","volume":"66","author":"JS Yang","year":"2018","unstructured":"Yang JS, Park Y. Insecticide exposure and development of nonalcoholic fatty liver disease. J Agric Food Chem. 2018;66(39):10132\u20138. \n                      https:\/\/doi.org\/10.1021\/acs.jafc.8b03177\n                      \n                    .","journal-title":"J Agric Food Chem"},{"issue":"8","key":"231_CR42","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1007\/s00204-016-1925-2","volume":"91","author":"P Marx-Stoelting","year":"2017","unstructured":"Marx-Stoelting P, Ganzenberg K, Knebel C, Schmidt F, Rieke S, Hammer H, et al. Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR\/hPXR mice. Arch Toxicol. 2017;91(8):2895\u2013907. \n                      https:\/\/doi.org\/10.1007\/s00204-016-1925-2\n                      \n                    .","journal-title":"Arch Toxicol"},{"issue":"1","key":"231_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.toxlet.2013.05.011","volume":"221","author":"K Tamura","year":"2013","unstructured":"Tamura K, Inoue K, Takahashi M, Matsuo S, Irie K, Kodama Y, et al. Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides. Toxicol Lett. 2013;221(1):47\u201356. \n                      https:\/\/doi.org\/10.1016\/j.toxlet.2013.05.011\n                      \n                    .","journal-title":"Toxicol Lett"},{"issue":"1","key":"231_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/toxsci\/kfm154","volume":"99","author":"RC Peffer","year":"2007","unstructured":"Peffer RC, Moggs JG, Pastoor T, Currie RA, Wright J, Milburn G, et al. Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicol Sci. 2007;99(1):315\u201325. \n                      https:\/\/doi.org\/10.1093\/toxsci\/kfm154\n                      \n                    .","journal-title":"Toxicol Sci"},{"key":"231_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2016.03.004","volume":"249","author":"AV Pirozzi","year":"2016","unstructured":"Pirozzi AV, Stellavato A, La Gatta A, Lamberti M, Schiraldi C. Mancozeb, a fungicide routinely used in agriculture, worsens nonalcoholic fatty liver disease in the human HepG2 cell model. Toxicol Lett. 2016;249:1\u20134. \n                      https:\/\/doi.org\/10.1016\/j.toxlet.2016.03.004\n                      \n                    .","journal-title":"Toxicol Lett"},{"key":"231_CR46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.toxlet.2016.09.013","volume":"262","author":"A Stellavato","year":"2016","unstructured":"Stellavato A, Lamberti M, Pirozzi AVA, de Novellis F, Schiraldi C. Myclobutanil worsens nonalcoholic fatty liver disease: an in vitro study of toxicity and apoptosis on HepG2 cells. Toxicol Lett. 2016;262:100\u20134. \n                      https:\/\/doi.org\/10.1016\/j.toxlet.2016.09.013\n                      \n                    .","journal-title":"Toxicol Lett"},{"issue":"1","key":"231_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12302-014-0014-5","volume":"26","author":"GE Seralini","year":"2014","unstructured":"Seralini GE, Clair E, Mesnage R, Gress S, Defarge N, Malatesta M, et al. Republished study: long-term toxicity of a roundup herbicide and a roundup-tolerant genetically modified maize. Environ Sci Eur. 2014;26(1):14. \n                      https:\/\/doi.org\/10.1186\/s12302-014-0014-5\n                      \n                    .","journal-title":"Environ Sci Eur"},{"key":"231_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep39328","volume":"7","author":"R Mesnage","year":"2017","unstructured":"Mesnage R, Renney G, Seralini GE, Ward M, Antoniou MN. Multiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of roundup herbicide. Sci Rep. 2017;7:39328. \n                      https:\/\/doi.org\/10.1038\/srep39328\n                      \n                    .","journal-title":"Sci Rep"},{"key":"231_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-015-0056-1","volume":"14","author":"R Mesnage","year":"2015","unstructured":"Mesnage R, Arno M, Costanzo M, Malatesta M, Seralini GE, Antoniou MN. Transcriptome profile analysis reflects rat liver and kidney damage following chronic ultra-low dose roundup exposure. Environ Health. 2015;14:70. \n                      https:\/\/doi.org\/10.1186\/s12940-015-0056-1\n                      \n                    .","journal-title":"Environ Health"},{"issue":"2","key":"231_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.chembiol.2016.12.013","volume":"24","author":"B Ford","year":"2017","unstructured":"Ford B, Bateman LA, Gutierrez-Palominos L, Park R, Nomura DK. Mapping proteome-wide targets of glyphosate in mice. Cell Chem Biol. 2017;24(2):133\u201340. \n                      https:\/\/doi.org\/10.1016\/j.chembiol.2016.12.013\n                      \n                    .","journal-title":"Cell Chem Biol"},{"issue":"4","key":"231_CR51","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/tox.22334","volume":"32","author":"C Mulligan","year":"2017","unstructured":"Mulligan C, Kondakala S, Yang EJ, Stokes JV, Stewart JA, Kaplan BL, et al. Exposure to an environmentally relevant mixture of organochlorine compounds and polychlorinated biphenyls promotes hepatic steatosis in male Ob\/Ob mice. Environ Toxicol. 2017;32(4):1399\u2013411. \n                      https:\/\/doi.org\/10.1002\/tox.22334\n                      \n                    .","journal-title":"Environ Toxicol"}],"container-title":["Current Environmental Health Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40572-019-00231-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40572-019-00231-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40572-019-00231-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T19:16:31Z","timestamp":1589310991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40572-019-00231-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1007\/s40572-019-00231-x","relation":{},"ISSN":["2196-5412"],"issn-type":[{"value":"2196-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"14 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain ant studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}